PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New RNA-based therapeutic strategies for controlling gene expression

New RNA-based therapeutic strategies for controlling gene expression
2012-02-06
(Press-News.org) New Rochelle, NY, February 2, 2012—Small RNA-based nucleic acid drugs represent a promising new class of therapeutic agents for silencing abnormal or overactive disease-causing genes, and researchers have discovered new mechanisms by which RNA drugs can control gene activity. A comprehensive review article in Nucleic Acid Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc., details these advances.

Short strands of nucleic acids, called small RNAs, can be used for targeted gene silencing, making them attractive drug candidates. These small RNAs block gene expression through multiple RNA interference (RNAi) pathways, including two newly discovered pathways in which small RNAs bind to Argonaute proteins or other forms of RNA present in the cell nucleus, such as long non-coding RNAs and pre-mRNA.

Keith T. Gagnon, PhD, and David R. Corey, PhD, University of Texas Southwestern Medical Center, in Dallas, review common features shared by RNAi pathways for controlling gene expression and focus in detail on the potential for Argonaute-RNA complexes in gene regulation and other exciting new options for targeting emerging forms of non-coding RNAs and pre-mRNAs in the article "Argonaute and the Nuclear RNAs: New Pathways for RNA Mediated Control of Gene Expression."

"The field of RNA mediated control of gene expression is rapidly evolving and the article by Gagnon and Corey provides a highly informative and up to date review of this exciting and often surprising area of biomedical research. We are delighted to publish this important review for the field," says Co-Editor-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center, Durham, NC.



INFORMATION:

Nucleic Acid Therapeutics is under the editorial leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, and C.A. Stein, MD, PhD, Department of Oncology, Albert Einstein-Montefiore Cancer Center, Montefiore Medical Center; and Executive Editor Fintan Steele, PhD (SomaLogic, Boulder, CO).

Nucleic Acid Therapeutics is an authoritative, peer-reviewed journal published bimonthly in print and online that focuses on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. Nucleic Acid Therapeutics is the official journal of the Oligonucleotide Therapeutics Society. A complete table of contents and free sample issue may be viewed online at www.liebertpub.com/nat.

Mary Ann Liebert, Inc. is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Human Gene Therapy and Human Gene Therapy Methods, Genetic Testing and Molecular Biomarkers, Assay and Drug Development Technologies, and DNA and Cell Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available at www.liebertpub.com

Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
www.liebertpub.com


[Attachments] See images for this press release:
New RNA-based therapeutic strategies for controlling gene expression

ELSE PRESS RELEASES FROM THIS DATE:

Hubble zooms in on a magnified galaxy

Hubble zooms in on a magnified galaxy
2012-02-06
Thanks to the presence of a natural "zoom lens" in space, NASA's Hubble Space Telescope got a uniquely close-up look at the brightest "magnified" galaxy yet discovered. This observation provides a unique opportunity to study the physical properties of a galaxy vigorously forming stars when the universe was only one-third its present age. A so-called gravitational lens is produced when space is warped by a massive foreground object, whether it is the sun, a black hole or an entire cluster of galaxies. The light from more-distant background objects is distorted, brightened ...

'First light' taken by NASA's newest CERES instrument

First light taken by NASAs newest CERES instrument
2012-02-06
The doors are open on NASA's Suomi NPP satellite and the newest version of the Clouds and the Earth's Radiant Energy System (CERES) instrument is scanning Earth for the first time, helping to assure continued availability of measurements of the energy leaving the Earth-atmosphere system. The CERES results help scientists to determine the Earth's energy balance, providing a long-term record of this crucial environmental parameter that will be consistent with those of its predecessors. CERES arrived in space Oct. 28, 2011, carried by NASA's newest Earth-observing satellite, ...

NASA satellites see wind shear battering Tropical Depression Iggy

NASA satellites see wind shear battering Tropical Depression Iggy
2012-02-06
NASA satellites have watched as wind shear has torn Cyclone Iggy apart over the last day. NASA infrared satellite imagery showed that Iggy's strongest thunderstorms have been pushed away from the storm's center and visible imagery shows the storm is being stretched out. Iggy is weakening and heading for a landfall between Geraldton and Perth. When NASA's Aqua satellite passed over Tropical Cyclone Iggy on Feb. 1 at 1805 UTC (1:05 p.m. EST), the Atmospheric Infrared Sounder (AIRS) instrument aboard captured an infrared look at the cyclone. AIRS data showed that the strongest ...

A battle of the vampires, 20 million years ago?

2012-02-06
CORVALLIS, Ore. – They are tiny, ugly, disease-carrying little blood-suckers that most people have never seen or heard of, but a new discovery in a one-of-a-kind fossil shows that "bat flies" have been doing their noxious business with bats for at least 20 million years. For bats, that's a long time to deal with a parasite doing its best vampire impression. Maybe it is nature's revenge on the vampire bat, an aggressive blood consumer in its own right that will feed on anything from sheep to dogs and humans. The find was made by researchers from Oregon State University ...

Breastfeeding and lung function at school age: Does maternal asthma modify the effect?

2012-02-06
Breastfeeding is associated with improved lung function at school age, particularly in children of asthmatic mothers, according to a new study from researchers in Switzerland and the UK. "In our cohort of school age children, breastfeeding was associated with modest improvement in forced mid-expiratory flow (FEF50) in our whole group and with improvements in forced vital capacity (FVC) and forced expiratory volume at 1 second (FEV1) only in the children of asthmatic mothers," said Claudia E. Kuehni, MD, MSc, professor at the Institute of Social and Preventive Medicine ...

Classic portrait of a barred spiral galaxy

Classic portrait of a barred spiral galaxy
2012-02-06
Most spiral galaxies in the Universe have a bar structure in their centre, and Hubble's image of NGC 1073 offers a particularly clear view of one of these. Galaxies' star-filled bars are thought to emerge as gravitational density waves funnel gas toward the galactic centre, supplying the material to create new stars. The transport of gas can also feed the supermassive black holes that lurk in the centres of almost every galaxy. Some astronomers have suggested that the formation of a central bar-like structure might signal a spiral galaxy's passage from intense star-formation ...

New procedure repairs severed nerves in minutes, restoring limb use in days or weeks

2012-02-06
American scientists believe a new procedure to repair severed nerves could result in patients recovering in days or weeks, rather than months or years. The team used a cellular mechanism similar to that used by many invertebrates to repair damage to nerve axons. Their results are published today in the Journal of Neuroscience Research. "We have developed a procedure which can repair severed nerves within minutes so that the behavior they control can be partially restored within days and often largely restored within two to four weeks," said Professor George Bittner from ...

New technique dissolves blood clots in the brain and lowers risk of brain damage after stroke

2012-02-06
Johns Hopkins neurologists report success with a new means of getting rid of potentially lethal blood clots in the brain safely without cutting through easily damaged brain tissue or removing large pieces of skull. The minimally invasive treatment, they report, increased the number of patients with intracerebral hemorrhage (ICH) who could function independently by 10 to 15 percent six months following the procedure. At the International Stroke Conference taking place January 31 through February 2 in New Orleans, the researchers will present their findings from 93 patients, ...

New technology to tackle treatment-resistant cancers

2012-02-06
Free-flowing cancer cells have been mapped with unprecedented accuracy in the bloodstream of patients with prostate, breast and pancreatic cancer, using a brand new approach, in an attempt to assess and control the disease as it spreads in real time through the body, and solve the problem of predicting response and resistance to therapies. In comparison to a previous generation of systems, the researchers state their test showed a significantly greater number of high-definition circulating tumour cells (HD-CTCs), in a higher proportion of patients, by using a computing-intensive ...

NYU Courant researchers weigh methods to more accurately measure genome sequencing

2012-02-06
Lost in the euphoria of the 2003 announcement that the human genome had been sequenced was a fundamental question: how can we be sure that an individual's genome has been read correctly? While the first full, individual genome was sequenced a decade ago, given the vast genetic variation across the world's seven billion people, not to mention the differences in makeup even among close relatives, the question of accurate sequencing for individuals has continued to vex researchers. With companies now projecting they can sequence a genome for a $1,000, down from $25,000 ...

LAST 30 PRESS RELEASES:

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

[Press-News.org] New RNA-based therapeutic strategies for controlling gene expression